DK248078A - Phatalaziner og fremgangsmaade til fremstilling deraf - Google Patents

Phatalaziner og fremgangsmaade til fremstilling deraf

Info

Publication number
DK248078A
DK248078A DK248078A DK248078A DK248078A DK 248078 A DK248078 A DK 248078A DK 248078 A DK248078 A DK 248078A DK 248078 A DK248078 A DK 248078A DK 248078 A DK248078 A DK 248078A
Authority
DK
Denmark
Prior art keywords
phatalazines
manufacture
methods
Prior art date
Application number
DK248078A
Other languages
Danish (da)
English (en)
Inventor
S F Campbell
J C Danilewicz
A G Evans
A L Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK248078A publication Critical patent/DK248078A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK248078A 1977-06-03 1978-06-02 Phatalaziner og fremgangsmaade til fremstilling deraf DK248078A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
DK248078A true DK248078A (da) 1978-12-04

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
DK248078A DK248078A (da) 1977-06-03 1978-06-02 Phatalaziner og fremgangsmaade til fremstilling deraf

Country Status (29)

Country Link
US (1) US4289772A (de)
JP (1) JPS5416488A (de)
AR (2) AR222013A1 (de)
AT (2) AT362792B (de)
AU (1) AU505373B1 (de)
BE (1) BE867727A (de)
CA (1) CA1111850A (de)
DD (1) DD137355A5 (de)
DE (1) DE2824064A1 (de)
DK (1) DK248078A (de)
EG (1) EG13527A (de)
ES (4) ES470470A1 (de)
FI (1) FI781753A (de)
FR (1) FR2392986A1 (de)
GB (1) GB2000136B (de)
GR (1) GR74402B (de)
HU (1) HU179745B (de)
IL (1) IL54842A (de)
IN (3) IN148482B (de)
IT (1) IT1094944B (de)
LU (1) LU79761A1 (de)
NL (1) NL7806016A (de)
NO (1) NO781935L (de)
NZ (1) NZ187453A (de)
PL (3) PL116437B1 (de)
PT (1) PT68126A (de)
SE (1) SE7806519L (de)
SU (2) SU856383A3 (de)
ZA (1) ZA783183B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PL135545B1 (en) * 1980-03-01 1985-11-30 Wyeth John & Brother Ltd Process for preparing novel derivatives of piperidine
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (de) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidinderivate und ihre Verwendung als Fungizide
WO1996036611A1 (en) * 1995-05-19 1996-11-21 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
WO1998007430A1 (fr) * 1996-08-20 1998-02-26 Eisai Co., Ltd. Medicament contre les defaillances de l'erection, renfermant un compose a base de pyridazine fondue
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
PL219749B1 (pl) * 2002-08-16 2015-07-31 Janssen Pharmaceutica Nv Pochodna piperydyny i jej zastosowanie oraz kompozycja farmaceutyczna ją zawierająca
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
EP1942879A1 (de) 2005-10-31 2008-07-16 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
CA2635439A1 (en) * 2006-01-27 2007-08-02 Pfizer Products Inc. Aminophthalazine derivative compounds
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht受容体介在性の神経新生
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
ES2367464T3 (es) 2007-08-07 2011-11-03 F. Hoffmann-La Roche Ag Pirrolidina-aril-éteres como antagonistas de receptor de nk3.
WO2009024502A1 (en) 2007-08-22 2009-02-26 F. Hoffmann-La Roche Ag Pyrrolidine aryl-ether as nk3 receptor antagonists
ATE549316T1 (de) * 2007-09-14 2012-03-15 Hoffmann La Roche Piperidinderivate als nk3-rezeptorantagonisten
WO2009040659A2 (en) 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
AU505373B1 (en) 1979-11-15
US4289772A (en) 1981-09-15
SU862826A3 (ru) 1981-09-07
FR2392986A1 (fr) 1978-12-29
NZ187453A (en) 1980-12-19
EG13527A (en) 1981-12-31
ATA305080A (de) 1980-12-15
GR74402B (de) 1984-06-28
IL54842A0 (en) 1978-08-31
ES470470A1 (es) 1979-09-01
NL7806016A (nl) 1978-12-05
ZA783183B (en) 1979-06-27
PL207337A1 (pl) 1979-06-04
ES478201A1 (es) 1980-02-01
FR2392986B1 (de) 1982-07-16
GB2000136B (en) 1982-01-06
JPS5538351B2 (de) 1980-10-03
IN148482B (de) 1981-03-07
IT7824106A0 (it) 1978-06-01
FI781753A (fi) 1978-12-04
IT1094944B (it) 1985-08-10
IL54842A (en) 1982-01-31
AR223999A1 (es) 1981-10-15
CA1111850A (en) 1981-11-03
AR222013A1 (es) 1981-04-15
PT68126A (en) 1978-07-01
SE7806519L (sv) 1978-12-04
BE867727A (fr) 1978-12-01
IN149550B (de) 1982-01-16
LU79761A1 (fr) 1980-01-22
AT362792B (de) 1981-06-10
ES478200A1 (es) 1980-01-01
NO781935L (no) 1978-12-05
DE2824064A1 (de) 1978-12-14
PL113208B1 (en) 1980-11-29
AT363096B (de) 1981-07-10
IN149973B (de) 1982-06-19
GB2000136A (en) 1979-01-04
SU856383A3 (ru) 1981-08-15
PL116437B1 (en) 1981-06-30
HU179745B (en) 1982-12-28
ES478199A1 (es) 1980-01-16
PL116420B1 (en) 1981-06-30
ATA400878A (de) 1980-11-15
DD137355A5 (de) 1979-08-29
JPS5416488A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
DK248078A (da) Phatalaziner og fremgangsmaade til fremstilling deraf
DK454178A (da) Acylanilider og fremgangsmaade til fremstilling deraf
DK137378A (da) Taeppe og fremgangsmaade til fremstilling deraf
DK102177A (da) Aminoalkyl-heterocycliske forbindelser og fremgangsmade til fremstilling deraf
DK389478A (da) Termoplastiske aromatiske polyetherketoner og fremgangsmaade til fremstilling deraf
DK556978A (da) Acylanilid og fremgangsmaade til fremstilling deraf
DK372878A (da) Thiadiazolylcephalosporinanaloge og fremgangsmaade til fremstilling deraf
DK319277A (da) Hydroxysuccinimidestere fremgangsmade til fremstilling heraf og anvendelse heraf
DK474078A (da) Endeloest forbindelsesbaand og fremgangsmaade til fremstilling deraf
DK502977A (da) Antracyklinderivat og fremgangsmaade til fremstilling deraf
DK335876A (da) 3-oximer af d-17alfa-ethynyl-19-nortestosteronestere og fremgangsmade til fremstilling deraf
DK308578A (da) Meningokokvaccine og fremgangsmaade til fremstilling heraf
DK495578A (da) Quinazolderivater og fremgangsmaade til fremstilling deraf
DK581378A (da) Keramisk form og fremgangsmaade til fremstilling deraf
DK96177A (da) 4-androsten-3-oner og fremgangsmade til fremstilling heraf
DK266578A (da) Herbicide cyklopropylmethoxyanilider og fremgangsmaade til fremstilling deraf
DK12478A (da) Dithienylalkylaminer og fremgangsmaade til fremstilling deraf
DK413578A (da) Isoquinolinderivater og fremgangsmaade til fremstilling deraf
DK554078A (da) Tetrapeptider og fremgangsmaade til fremstilling deraf
DK224279A (da) Polyjodbenzenderivater og fremgangsmaade til fremstilling deraf
DK151570C (da) Afsvovlningsmiddel og fremgangsmaade til fremstilling deraf
DK270279A (da) Cystaminderivater og fremgangsmaade til fremstilling deraf
DK213878A (da) 17beta-hydroxy-4-androsten-3-on og fremgangsmaade til fremstilling heraf
DK54678A (da) Azetidinonderivater og fremgangsmaade til fremstilling deraf
DK111578A (da) Steroid/spirooxazolidiner og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment